John Goetz
John Goetz, the executive vice president and chief operating officer of Bio-Rad Laboratories, will retire and resign from his position effective March 30, 2018, but will remain available for consultation after his employment ends if a successor has not yet been named. Goetz has been with Bio-Rad for more than 40 years and was named COO in 2014.
Shawn Clairmont
Codexis has appointed Shawn Clairmont senior director of molecular diagnostics. She will be responsible for commercial activities related to the firm's molecular diagnostics enzyme product line in development. Clairmont previously served as chief operating officer of BRIDGenomics. She was with Qiagen for eight years, most recently in the global advanced molecular pathology team as director of sales in America, and was also technical marketing representative and account manager at BioArray Solutions (now part of Immucor).
Michael Pellini
Adaptive Biotechnologies announced that former Foundation Medicine CEO Michael Pellini has joined its board. Pellini is currently chairman of Foundation Medicine's board, and is a managing partner of life science venture capital firm Section 32. He previously was president and chief operating officer of Clarient, which was acquired by GE Healthcare in 2010. He currently also serves on the boards of Tango Therapeutics, Singular Genomics, the Personalized Medicine Coalition, and the Mission Hospital Foundation.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.